Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tellsparck
    Member
    • May 2012
    • 19

    Denovo transcriptome assembly

    Hi Forum,
    We have some RNA-Seq data generated using Nugen's Ovation RNA-Seq System V2 kit.I plan to do denovo transcript assembly using cufflinks with this data. But when I look at the BAM files, I see many genes which have quite a lot of reads in introns. My feeling is that most of it comes from pre-mRNA (the kit uses both random primers and oligo-dT primers) although a fraction of it may be biologically meaningful (retained introns/alternate exons etc). Does anyone have any experience with denovo assembly using libraries made with this or similar kits? Thanks!
  • tellsparck
    Member
    • May 2012
    • 19

    #2
    Hi, just to give more details about my concerns, Since cufflinks depends on junction reads for denovo assembly, having lots of premRNA will affect these types of reads and I have no idea how this will affect the results...
    Thanks!

    Comment

    • Mocca
      Junior Member
      • Mar 2012
      • 9

      #3
      Try using another assembler that handles isoform resolving differently. I work with Trinity and find that good (2n vertebrate species) however it struggles a bit with paralogs and I also find retained introns (might be artefacts, might not). Any genome resources available to you (same or closely related species)? If yes, you could try a mixed approach with de novo first and then map the transcripts to the genome reference. Best of luck :-)

      Comment

      • tellsparck
        Member
        • May 2012
        • 19

        #4
        Thanks for your input Mocca.
        My samples are from mouse (my bad not mentioning it the first time around) and originally, the idea was to use cufflinks because it is a genome guided assembler. I saw that Trinity has a genome guided version now- have you used it and do you have any advice on that?
        Thanks!

        Comment

        • Mocca
          Junior Member
          • Mar 2012
          • 9

          #5
          Having a model species gives you more alternatives. Trinity genome guided worked OK for me, but its difficult to compare as I work on a non-model species. Trinity would cluster your RNAseq reads according to chromosome (and any scaffolds not connected to a chromosome) and then assemble each cluster de novo. You could then for example take the trinity transcripts and map them to the genome and see how they behave. There are also some good papers on mixed approaches: de novo first and then mapping towards reference, concatenation of several transcriptome assemblies based on various parameteres etc. depending on what you are interested in.

          Hope you find an approach that fits your project :-)
          Last edited by Mocca; 10-10-2015, 03:52 AM. Reason: Posten to quickly.

          Comment

          Latest Articles

          Collapse

          • mylaser
            Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by mylaser
            Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
            If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
            This guide explains everything you need to know about...
            Today, 01:13 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          10 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-02-2026, 11:08 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Working...